American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | PNTG | ATAI | ||
| Company | American Renal Associates | The Pennant Group Inc | Atai Life Sciences N.V. | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 11.48 | 30.96 | 1.5900 | ||
| High | 11.52 | 31.29 | 1.6000 | ||
| Low | 11.33 | 30.30 | 1.5100 | ||
| Last | 11.52 | 30.50 | 1.5200 | ||
| Change | +0.02 | -0.28 | -0.0700 | ||
| % Change | +0.17% | -0.91% | -4.40% | ||
| Volume | 9,800 | 282,500 | 1,265,800 | ||
| 20-Day Average Volume | 110,105 | 241,770 | 2,226,300 | ||
| Previous Close | 11.50 | 30.78 | 1.5900 | ||
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 32.48 | 1.3370 | ||
| 20-Day Raw Stochastic | 100.00% | 30.41% | 52.75% | ||
| 20-Day Relative Strength | 70.89% | 41.36% | 57.34% | ||
| Weighted Alpha | -7.72 | +101.12 | +7.36 | ||
| Today's Opinion | 100% Buy | 24% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 24% Buy | 24% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | -4.39% since 11/14/24 | +10.95% since 11/14/24 | ||
| Low | 11.33 on 01/25/21 | 30.25 on 11/20/24 | 1.4300 on 11/15/24 | ||
| High | 11.52 on 01/25/21 | 32.28 on 11/15/24 | 1.9500 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | -7.15% since 10/21/24 | +26.67% since 10/21/24 | ||
| Low | 11.33 on 01/25/21 | 28.80 on 11/07/24 | 1.0400 on 10/31/24 | ||
| High | 11.52 on 01/25/21 | 34.82 on 10/24/24 | 1.9500 on 11/18/24 | ||
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | -7.27% since 08/21/24 | +14.29% since 08/21/24 | ||
| Low | 11.33 on 01/25/21 | 28.80 on 11/07/24 | 1.0300 on 10/11/24 | ||
| High | 11.52 on 01/25/21 | 37.13 on 09/25/24 | 1.9500 on 11/18/24 | ||
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | +28.80% since 05/21/24 | -9.52% since 05/21/24 | ||
| Low | 6.08 on 09/21/20 | 21.97 on 06/24/24 | 1.0300 on 10/11/24 | ||
| High | 11.98 on 10/06/20 | 37.13 on 09/25/24 | 1.9500 on 11/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 1,057,231 | 266,805 | ||
| Shares Outstanding, K | 34,543 | 34,348 | 167,802 | ||
| Annual Sales | 822,520,000 | 544,890,000 | 310,000 | ||
| Annual Net Income | -13,790,000 | 13,380,000 | -40,220,000 | ||
| Last Quarter Sales | 209,690,000 | 180,690,000 | 40,000 | ||
| Last Quarter Net Income | -2,690,000 | 6,210,000 | -26,290,000 | ||
| 60-Month Beta | 1.11 | 2.02 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.26 on 11/06/24 | -0.16 on 11/13/24 | ||
| Latest Earnings Date | 03/15/21 | 11/06/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 06/08/17 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 44.18 | 0.00 | ||